The Banks Have Started Working the Room — Countdown to Anthropic's Listing

Here's the deal: on July 15, a quiet-looking headline landed with real weight. The banks running Anthropic's stock-market debut had started scheduling investor meetings, according to reports from CNBC and Bloomberg, each citing people familiar with the plans. The lead underwriters are Morgan Stanley, Goldman Sachs, and JPMorgan. When those three names start walking a deck around to investors, it's the decisive signal that an IPO has flipped from "someday" to "soon." The target window is as early as this October.

The numbers explain why this matters. Anthropic's most recent private valuation was $965 billion — the mark it hit just two months earlier, in late May, when it closed a $65 billion Series H round. The market consensus is that a public debut clears that figure and crosses $1 trillion. If it happens, this isn't just another large IPO. It would be the first time a company that builds frontier AI models itself steps onto public markets. Not a chip maker like Nvidia, not an infrastructure company like Databricks — a company that sells the models themselves, standing for the first time in front of the daily vote of tens of thousands of buyers.

One thing to nail down first. The only confirmed fact right now is that the underwriters have begun investor meetings. There's no offer price, no share count, no exchange, no ticker. The $1 trillion figure isn't a company target either — it's reporting and market estimate. Even "October" comes hedged with "as early as," and it can slip depending on SEC review and market conditions. So attach a mental footnote to every valuation number in this piece: this is not yet a price the exchange has set.

The Players — a Four-Year-Old Company at a Trillion, and Three Banks

Start with Anthropic. It was founded in 2021 by researchers who left OpenAI, including Dario Amodei and his sister Daniela Amodei. The founding thesis was explicit: build AI more safely. That's why the company took a public-benefit corporation (PBC) structure and put safety research like "Constitutional AI" front and center. The product is a family of large language models called Claude. Early on it wore the number-two image behind OpenAI's GPT, but the picture changed as Claude built real presence in coding, agents, and the enterprise.

The decisive lever was Claude Code, a tool that lets developers write and edit code from the terminal in natural language. It sold explosively, and a big chunk of Anthropic's revenue surge traces back to it. There's a structural quirk to that revenue worth flagging: Anthropic leans more on API-consumption revenue than on chatbot subscriptions. Enterprises and developers pay per token to call Claude — directly, and through Amazon Bedrock and Google Cloud's Vertex. That detail connects later to the question of why revenue recognition can become a debate during the listing review.

The trio of banks isn't a random lineup either. Morgan Stanley is the go-to lead for big Silicon Valley tech IPOs; it was the lead underwriter on Facebook's 2012 listing and has steered many major tech debuts since. Goldman Sachs is a traditional heavyweight in IPO advisory and underwriting, and JPMorgan brings the largest balance sheet and institutional network to the table. Three firms of that caliber on a single deal signals that Anthropic is designing this listing at a "one-for-the-history-books" scale. Worth noting: word that Anthropic had picked these three as underwriters had circulated since the spring — the July reporting is the next step, the banks actually starting to call investors.

And you can't leave out Dario Amodei himself. He's a person who publicly and forcefully insists AI will reshape the world within a few years, and he's also been relatively transparent about Anthropic's financial trajectory. This IPO puts that conviction directly onto the public market's testing stand. Convincing a few dozen private investors and being priced every morning by a live stock quote are entirely different games.

What Actually Happened — the Last Step From $965B to $1T

Laid out in order, the picture sharpens. Anthropic closed its Series H on May 28. The round was $65 billion, pushing post-money valuation to $965 billion. Altimeter, Dragoneer, Greenoaks, and Sequoia led, with Capital Group, Coatue, GIC, ICONIQ, and others as co-leads. It included $15 billion of previously committed hyperscaler money — Amazon's $5 billion among it — plus strategic investment from infrastructure partners like Micron, Samsung, and SK hynix. That round made Anthropic the most valuable startup in the world, overtaking OpenAI on valuation.

Less than two months later, on July 15, came the report that the underwriters had started working the investor circuit — the company actually beginning to cross the bridge from private to public. Track the revenue trajectory and you understand why the banks are moving now. The run-rate figures reported were roughly: ~$9 billion at the end of 2025 → ~$14 billion in February 2026 → past $30 billion in April → $47 billion by late May. Roughly a fivefold jump in a little over half a year. In its May 20 report, CNBC added that a source expected Anthropic to book about $10.9 billion in revenue in the second quarter. There is essentially no other company in AI adding revenue at this pace right now.

But here's the caution. Most of these revenue numbers are reporting that cites sources, not official company disclosures. The run-rate metric itself — "recent monthly or quarterly revenue times twelve" — tends to look larger than actual annual revenue precisely when growth is steep. Anthropic's actual realized 2025 revenue was reported around $10 billion, which is a different concept from the year-end run-rate ($9 billion). How the auditors and the SEC recognize this revenue during the listing review will shape the real foundation under the valuation. That's why you shouldn't read the headline "$47 billion" as literally "this company's annual revenue."

Item Detail
Report date July 15, 2026 (CNBC, Bloomberg)
Confirmed fact Underwriters have started investor meetings
Target window As early as October 2026 (subject to SEC review, market conditions)
Lead underwriters Morgan Stanley, Goldman Sachs, JPMorgan
Last private valuation $965 billion (Series H, closed 2026-05-28)
Series H size $65 billion ($15B hyperscaler commitments incl. Amazon's $5B)
Expected IPO valuation Above $1 trillion — reporting/market estimate, not company-confirmed
Run-rate trajectory ~$9B end-2025 → ~$14B Feb → $30B+ April → $47B late May (reported)
Q2 revenue estimate ~$10.9 billion (CNBC, citing a source)
Undecided Offer price, share count, exchange, ticker — all TBD
Rival status OpenAI filed a confidential S-1 in spring, weighing a 2027 listing

The most important row is the second one: the only thing confirmed right now is "meetings have started," and everything else is fluid. IPOs routinely slip by days when markets wobble mid-roadshow. So the precise meaning of this news isn't "Anthropic will list in October" — it's "Anthropic has actually switched on the listing process, aimed at October."

What Each Side Gets — the Company, Employees, Investors, and Why the Rush

What Anthropic gets breaks down three ways. First, capital at overwhelming scale. The compute cost of building AI models is beyond anything most people picture. Training and serving Claude eats enormous GPU and data-center spending, and it needs vast, repeatable funding — and public markets are a far bigger and more repeatable window than private rounds. Second, liquidity. Employees' stock options and the stakes of early and mid-stage investors get a path to actual cash. In a market where frontier labs poach each other's talent with multi-million-dollar packages, "our stock can now be sold every day" is a powerful hiring and retention weapon. Third, the banner. The title of the world's first publicly listed AI lab is itself a trust asset in enterprise sales.

Employees and existing investors see their paper value rise with the valuation, but a listing is about whether that value can actually be realized. They can't sell before the lockup ends, and if the stock trades below the offer price on day one, investors who came in expensive in the last private round can take a loss. A high valuation also means the burden of defending that number after the debut.

The three underwriters get something clear: underwriting fees on one of the largest IPOs ever, plus the reference line "we led the first AI-lab listing." That prestige becomes a recurring weapon in the competition to underwrite OpenAI and other AI listings still to come.

So why now, and why the rush? Here's the most interesting strategic point. Reaching public markets before your rival is itself an advantage. Being first to list lets you seize the benchmark in a brand-new category of "AI-lab stocks." When investors later value a company like OpenAI, they'll reach for "so many times relative to Anthropic." And opening the window while the market's enthusiasm for AI stocks runs hot is far better than opening it after the mood cools. Nobody knows when the window slams shut.

Precedents That Worked and Precedents That Didn't — Google, Meta, and the Shadows of WeWork and Snowflake

The history of big tech IPOs has textbook successes and failures sitting side by side. The poster child for success is Google. It listed in 2004 via an unusual Dutch-auction format, and early skeptics called it too expensive — the IPO market cap was around $23 billion. But the cash engine of search advertising was so strong that the stock rose many-fold over the long run. Meta (then Facebook) stumbled on its 2012 debut day — Morgan Stanley was the lead and sweated to defend the opening price — but eventually proved itself on mobile advertising and climbed. The common thread is clear: they grew into their lofty listing-day valuations through earnings.

On the other side sits WeWork. SoftBank marked it at $47 billion in 2019, but the financials revealed during IPO prep failed to earn the market's trust, and the listing was pulled. It filed for bankruptcy in 2023 — the canonical case of a private mark the public market ultimately refused to ratify. Snowflake is a different kind of warning. It debuted spectacularly in 2020 at close to 200 times revenue, but as growth cooled from triple digits, the stock fell hard from its peak. The late private-round investors and day-one buyers took the biggest hits. It's the case study in what happens when valuation runs far ahead of the growth curve.

There's one fresher warning aimed straight at Anthropic. One of the things reportedly triggering OpenAI's move to consider delaying its listing was SpaceX's underwhelming market debut. No matter how powerful a company's story is, the market can react coldly on day one — and OpenAI watched that happen in real time, right next door. It's both a reason Anthropic is pushing now and a reason to be scared.

So the core question is this: is Anthropic more like Google and Meta, or more like Snowflake and WeWork? The bull case is that its revenue is growing at a pace with no historical precedent. The bear case is that a large share of that revenue still comes alongside massive compute losses, and that the revenue-recognition method could land on the operating table during the listing review. Those two stories will pull against each other, taut, all the way to October.

How OpenAI Counters — and How the Board Gets Redrawn

The most direct rival is, of course, OpenAI. But the two companies' listing races have crossed in a strange way. OpenAI moved first — it was reported to have confidentially filed an S-1 with the SEC in the spring. Its valuation stood at $852 billion as of March, and it was aiming for $1 trillion at listing. Then the mood shifted in June, when Reuters and others reported that OpenAI was weighing a delay to 2027. The reason was valuation: Sam Altman reportedly called listing below $1 trillion a "nonstarter." Fetching a higher number requires firming up the financials first, and that takes time.

This is where the two strategies diverge head-on. If OpenAI chose "wait until we get full price," Anthropic effectively chose "get there first." If Anthropic actually lists in October, Anthropic is the one that reaches the market first — even though OpenAI filed its paperwork earlier in the spring. A wry setup: the company that filed first may not be the one that rings the bell first.

OpenAI has a few cards. One is simply to wait. If Anthropic's listing sells well, it's proof that "the market wants AI labs," which gives OpenAI grounds to enter later at a higher valuation. Conversely, if Anthropic's debut is lukewarm, OpenAI can claim its own judgment — "still too early" — was right. Another card is switching to a speed play, opening its own window before Anthropic locks in the benchmark. But since Altman has drawn a line on valuation, that card only comes out when the market is unmistakably hot.

The competition isn't only in the listing race. Google DeepMind (Gemini), xAI (Grok), and the open-source camp make the model market itself a battlefield. If Anthropic pours the capital and brand it secures from a listing into compute and talent, the stakes of that competition ratchet up a notch. On the flip side, the burden of disclosing results every quarter as a public company can constrain some of the "freedom to make long-term bets" it enjoyed while private. There's now a permanent tension between the market wanting next quarter's revenue and the company wanting to look at AGI five years out.

So What Actually Changes

If you're a developer — your Claude or Claude Code experience won't change tomorrow. But the direction matters. If a listing brings in large capital, it expands the compute headroom for training and serving models, which can feed through to model quality and service reliability. There's a flip side to watch, too: as a public company, Anthropic faces quarterly earnings pressure, and the generosity of free or low tiers and API pricing policy could get rebalanced between "growth" and "profitability." If your team has piped deep dependencies into Claude's API, it's worth stress-testing your pricing and policy scenarios for the post-listing world.

If you're an investor — three cautions. First, the only thing confirmed is that meetings began — offer price, timing, and exchange are all undecided. "October listing" is a target, not a fixed date. Second, the $1 trillion figure is reporting and market estimate, not a company disclosure. Third, most of the revenue numbers are source-cited reporting, and remember that run-rate metrics look larger than actual annual revenue precisely when growth is steep. One more: an AI lab's listing is a new category with no clean comparables, so there's no consensus yet on what a "fair" valuation is. That also means potentially high early volatility — a stretch retail investors should be especially careful about if they jump in right after the debut.

If you're a general user — whether Anthropic lists or not makes no difference to using Claude today. But there's an indirect meaning. If this company goes public, it becomes one more stock you might indirectly own through a pension or fund. And zooming out, whether the first AI-lab listing sells well becomes a litmus test for how much money, and how fast, flows into this industry going forward. A successful listing sustains the AI-investment fever, which loops back as AI features arriving faster in the services you use. A cold debut, and fundraising across the sector could get a beat more cautious. But that outcome requires an actual listing first — and that isn't settled yet.

🥄 Three Things You're Probably Wondering

— So what does this mean for me? Directly, not much — your experience of Claude won't change tomorrow. But if the company lists, it becomes a stock that could sit indirectly in your pension or fund, and whether the first AI-lab IPO sells well is a signal for how fast money will pour into the AI industry from here.

— So is the October listing locked in? No. The only confirmed thing is that the underwriters have started investor meetings. Offer price, share count, exchange, and ticker are all TBD, and "October" comes with an "as early as." IPOs routinely slip when markets wobble mid-roadshow, so it's too soon to call it done.

— Is Anthropic really ahead of OpenAI? On listing order, likely yes. OpenAI filed its paperwork confidentially first in the spring, but it's weighing a delay to 2027 because it won't concede on valuation. If Anthropic actually rings the bell in October, it reaches the market first. But calling it "ahead" on valuation and revenue scale too is something you only know once the listing lid comes off.

Further Reading

Numbers and criteria are as of announcement and may change. Investment calls are yours to make!